News and results covered here feature plenty of fast-growing UK companies, with many having notable success in overseas markets. While the ratings of several look quite full, recent share price weakness from others means the shares look considerably more appealing. We have also published updates from some our Stonking Small Cap and Bonkers Bargain opportunities.
Diaceutics: on track to return to profitability Diaceutics (AIM: DXRX), a technology and solutions provider to the pharma and biotech industry, announced strong growth in its half year results, all that was missing were some profits, but these appear to be imminent! Diaceutics provides leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by their platform DXRX - The Diagnostics Network®. Management believes that DXRX can deliver up to $100 in additional therapy revenue for every $1 invested by its customers. In the 6 months to 30 June…
Sign up and read the full article
Register to continue reading our content.
Get FREE access now
Already a member? Login